Investigation of the 6He cluster structures

The 4He+2n and t+t clustering of the 6He ground state were investigated by means of the transfer reaction 6He(p,t)4He at 25 MeV/nucleon. The experiment was performed in inverse kinematics at GANIL with the SPEG spectrometer coupled to the MUST array. Experimental data for the transfer reaction were analyzed by a DWBA calculation including the two neutrons and the triton transfer. The couplings to the 6He --> 4He + 2n breakup channels were taken into account with a polarization potential deduced from a coupled-discretized-continuum channels analysis of the 6He+1H elastic scattering measured at the same time. The influence on the calculations of the 4He+t exit potential and of the triton sequential transfer is discussed. The final calculation gives a spectroscopic factor close to one for the 4He+2n configuration as expected. The spectroscopic factor obtained for the t+t configuration is much smaller than the theoretical predictions.Comment: 10 pages, 11 figures, accepted in PR

Structure of low-lying states of 10,11^{10,11}C from proton elastic and inelastic scattering

NESTER PTH, expérience GANIL, équipement SISSITo probe the ground state and transition densities, elastic and inelastic scattering on a proton target were measured in inverse kinematics for the unstable $^{10}$C and $^{11}$C nuclei at 45.3 and 40.6 MeV/nucleon, respectively. The detection of the recoil proton was performed by the MUST telescope array, in coincidence with a wall of scintillators for the quasiprojectile. The differential cross sections for elastic and inelastic scattering to the first excited states are compared to the optical model calculations performed within the framework of the microscopic nucleon-nucleus Jeukenne-Lejeune-Mahaux potential. Elastic scattering is sensitive to the matter-root-mean square radius found to be 2.42$\pm$0.1 and 2.33$\pm$0.1 fm, for $^{10,11}$C, respectively. The transition densities from cluster and mean-field models are tested, and the cluster model predicts the correct order of magnitude of cross sections for the transitions of both isotopes. Using the Bohr-Mottelson prescription, a profile for the $^{10}$C transition density from the $0^+$ ground to the $2_1^+$ state is deduced from the data. The corresponding neutron transition matrix element is extracted: Mn=5.51$\pm$1.09 fm$^2$

Indication for the disappearance of reactor electron antineutrinos in the Double Chooz experiment

The Double Chooz Experiment presents an indication of reactor electron antineutrino disappearance consistent with neutrino oscillations. A ratio of 0.944 $\pm$ 0.016 (stat) $\pm$ 0.040 (syst) observed to predicted events was obtained in 101 days of running at the Chooz Nuclear Power Plant in France, with two 4.25 GW$_{th}$ reactors. The results were obtained from a single 10 m$^3$ fiducial volume detector located 1050 m from the two reactor cores. The reactor antineutrino flux prediction used the Bugey4 measurement as an anchor point. The deficit can be interpreted as an indication of a non-zero value of the still unmeasured neutrino mixing parameter \sang. Analyzing both the rate of the prompt positrons and their energy spectrum we find \sang = 0.086 $\pm$ 0.041 (stat) $\pm$ 0.030 (syst), or, at 90% CL, 0.015 $<$ \sang $\ <$ 0.16.Comment: 7 pages, 4 figures, (new version after PRL referee's comments

Structure of exotic nuclei from direct reactions

Expérience GANILInternational audienc

Charge-exchange reaction with light neutron-rich beams

The charge exchange reaction p(6He, 6Li) was studied in reverse kinematics with a secondary 6He beam at 41.6 MeV/nucleo

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)

Structure of light exotic nuclei 6,8^{6,8}He and 10,11^{10,11}C from (p,p') reactions

NESTERThe structure of the light unstable nuclei 10,11C and 6,8He is investigated by means of (p,p′) reactions. The experiments were performed at GANIL using the MUST detector, an array of Si and SiLi telescopes. The (p,p′) are analyzed within the framework of the microscopic JLM potential, allowing to test the densities predicted by structure models. Preliminary data from the 8He(p,o′) reaction performed at the SPIRAL facility at 15.6 MeV/nucleon are discussed

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362